← All companies
DARE
Daré Bioscience, Inc.
$1.32
+0.04 +3.13%
Key statistics
from XBRL data in SEC filingsMarket cap
$19.8M
Revenue (TTM)
$1.03M
Net income (TTM)
-$12.0M
EPS (TTM)
$-0.91
P/E ratio
—
Dividend yield
—
Free cash flow
-$10.3M
Cash
$18.5M
Total assets
$27.8M
Gross margin
—
52-week range
$1.13 – $3.78
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 24, 2026
8-K
Delisting notice or listing-rule failure
Jul 17, 2026
8-K
Regulation FD disclosure
Jul 13, 2026
8-K
Regulation FD disclosure
Jun 22, 2026
8-K
Director or officer change; Shareholder vote results
Jun 12, 2026
8-K
Unregistered sale of equity
May 18, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Results of operations (earnings release)
May 14, 2026
8-K
Unregistered sale of equity
May 7, 2026
8-K
Regulation FD disclosure
Apr 22, 2026
8-K
Unregistered sale of equity
Apr 20, 2026
8-K
Director or officer change
Apr 17, 2026
8-K
Unregistered sale of equity
Apr 13, 2026
10-K
Fiscal year ended 2025-12-31
Mar 26, 2026
8-K
Results of operations (earnings release)
Mar 26, 2026
8-K
Unregistered sale of equity
Mar 17, 2026
8-K
Unregistered sale of equity
Mar 9, 2026
8-K
Regulation FD disclosure
Mar 2, 2026
8-K
Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Other events
Jan 29, 2026
8-K
Regulation FD disclosure
Jan 6, 2026
8-K
Terminated a material agreement; Regulation FD disclosure
Dec 1, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Results of operations (earnings release)
Nov 13, 2025
8-K
Regulation FD disclosure
Sep 2, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K
Other events
Jul 25, 2025
8-K
Other events
Jul 21, 2025
8-K
Regulation FD disclosure; Other events
Jul 14, 2025
8-K
Director or officer change; Shareholder vote results
Jul 9, 2025
8-K
Other events
Jun 25, 2025
8-K
Regulation FD disclosure
Jun 9, 2025
10-Q
Quarter ended 2025-03-31
May 13, 2025
8-K
Results of operations (earnings release)
May 13, 2025
8-K
Other events
Apr 11, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Results of operations (earnings release)
Mar 31, 2025
8-K
Delisting notice or listing-rule failure
Feb 14, 2025
8-K
Regulation FD disclosure
Feb 10, 2025
8-K
Regulation FD disclosure
Jan 13, 2025